Cite

HARVARD Citation

    Caram, M. et al. (2020). Adherence and out‐of‐pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Cancer. 126 (23), pp. 5050-5059. [Online]. 
  
Back to record